These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Quantitative structure-activity relationship for prediction of the toxicity of polybrominated diphenyl ether (PBDE) congeners. Wang Y; Zhao C; Ma W; Liu H; Wang T; Jiang G Chemosphere; 2006 Jul; 64(4):515-24. PubMed ID: 16406101 [TBL] [Abstract][Full Text] [Related]
23. The dawning of a new age of toxicology. Leist M; Hartung T; Nicotera P ALTEX; 2008; 25(2):103-14. PubMed ID: 18551234 [TBL] [Abstract][Full Text] [Related]
25. Baccalaureate program in toxicology. Lage GL Vet Hum Toxicol; 1979 Jun; 21(3):191. PubMed ID: 462741 [TBL] [Abstract][Full Text] [Related]
26. Guidelines for medical toxicology fellowship programs. American Board of Medical Toxicology. American College of Emergency Physicians, Toxicology Committee. Ann Emerg Med; 1990 Jun; 19(6):689-90. PubMed ID: 2344088 [No Abstract] [Full Text] [Related]
27. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens. Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342 [TBL] [Abstract][Full Text] [Related]
28. Preface: differential quantitative structure-activity relationship (DiffQSAR) in the characterization of emerging drug resistance. Basak SC Curr Comput Aided Drug Des; 2014 Mar; 10(1):1-2. PubMed ID: 24801103 [No Abstract] [Full Text] [Related]
29. In silico methods for early toxicity assessment. Merlot C Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270 [TBL] [Abstract][Full Text] [Related]
30. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products. Kruhlak NL; Contrera JF; Benz RD; Matthews EJ Adv Drug Deliv Rev; 2007 Jan; 59(1):43-55. PubMed ID: 17229485 [TBL] [Abstract][Full Text] [Related]
32. [Use of structure-activity analysis in toxicology]. Laass W Arch Exp Veterinarmed; 1978; 32(4):579-84. PubMed ID: 727870 [TBL] [Abstract][Full Text] [Related]
33. American Board of Medical Toxicology of the American Academy of Clinical Toxicology, Inc.: requirements for eligibility to take the examination. Lovejoy FH Vet Hum Toxicol; 1979 Oct; 21(5):377. PubMed ID: 516376 [No Abstract] [Full Text] [Related]
34. Benefits of a close relationship between drug information centers and research laboratories. Vessell ES Drug Inf J; 1975; 9(2-3):190-1. PubMed ID: 10236974 [No Abstract] [Full Text] [Related]
35. The use of in vitro data in risk assessment. Bernauer U; Oberemm A; Madle S; Gundert-Remy U Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):176-81. PubMed ID: 15733212 [TBL] [Abstract][Full Text] [Related]
36. [In silico, in vitro, in omic experimental models and drug safety evaluation]. Claude N; Goldfain-Blanc F; Guillouzo A Med Sci (Paris); 2009 Jan; 25(1):105-10. PubMed ID: 19154704 [TBL] [Abstract][Full Text] [Related]